wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38763633-7126F444-1D51-4622-B561-44F0D67490FE
Q38763633-7126F444-1D51-4622-B561-44F0D67490FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38763633-7126F444-1D51-4622-B561-44F0D67490FE
Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?
P2860
Q38763633-7126F444-1D51-4622-B561-44F0D67490FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38763633-7126F444-1D51-4622-B561-44F0D67490FE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cf7e18caf769c323eb2858083a3f3ca90a620c09
P2860
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.